Crescent Grove Advisors, LLC - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 225 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
Crescent Grove Advisors, LLC ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$21,600
+10.8%
60,000
+172.7%
0.00%
+50.0%
Q4 2022$19,492
-40.9%
22,000
+4.8%
0.00%
-50.0%
Q3 2022$33,000
-17.5%
21,000
+5.0%
0.00%0.0%
Q2 2022$40,000
-14.9%
20,0000.0%0.00%
-20.0%
Q1 2022$47,000
-76.5%
20,000
-53.5%
0.01%
-73.7%
Q4 2021$200,000
+19.0%
43,000
+95.5%
0.02%
+5.6%
Q3 2021$168,000
-13.4%
22,000
+10.0%
0.02%
-10.0%
Q2 2021$194,00020,0000.02%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Oaktree Fund Advisors, LLC 66,000$503,00048.93%
SABBY MANAGEMENT, LLC 1,698,107$12,957,0001.75%
EMFO, LLC 233,008$1,778,0001.57%
swisspartners Ltd. 110,000$839,0000.65%
HERITAGE WEALTH MANAGEMENT, LLC 150,000$1,145,0000.41%
Donald L. Hagan, LLC 42,929$328,0000.19%
COLLECTIVE FAMILY OFFICE LLC 44,203$337,0000.14%
Spectrum Wealth Advisory Group, LLC 18,093$138,0000.14%
NEXPOINT ASSET MANAGEMENT, L.P. 100,000$763,0000.13%
Cormorant Asset Management, LP 400,000$3,052,0000.12%
View complete list of SORRENTO THERAPEUTICS INC shareholders